메지온, 47억대 손해배상 소송 승소…"청구 기각"

Meji-On successfully defended against a former executive's 4.7 billion won lawsuit over stock option disputes, with the court dismissing the claim entirely. This ruling strengthens the company's legal position and validates its executive compensation frameworks in the biomedical research sector.